anonymous
Guest
anonymous
Guest
Viehbacher was very careful with his words. Plan is to reduce headcount BY 2025. That doesn’t it won’t happen next week either. Biogen has no incentive to slowly roll this out. They know that employees start losing motivation and start looking the minute layoffs are announced. Biogen wants to dictate the terms of who gets cut So I wouldn’t be surprised we’re told to wait by our phones this month. Also, the MS revenue has dropped by 15% and no growth for the biosimilar team. I anticipate cuts to be deep with these two franchises. Good luck to all